Compare XBP & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBP | TOI |
|---|---|---|
| Founded | 2020 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.7M | 346.3M |
| IPO Year | N/A | N/A |
| Metric | XBP | TOI |
|---|---|---|
| Price | $7.13 | $3.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 43.0K | ★ 1.5M |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $62,823,000.00 | ★ $461,039,000.00 |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | N/A | $23.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | $4.11 | $0.25 |
| 52 Week High | $25.60 | $4.88 |
| Indicator | XBP | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 83.84 | 53.95 |
| Support Level | $6.27 | $3.23 |
| Resistance Level | $6.97 | $3.75 |
| Average True Range (ATR) | 0.56 | 0.22 |
| MACD | 0.16 | 0.02 |
| Stochastic Oscillator | 96.61 | 54.19 |
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.